Response to convalescent plasma is not influenced by patient blood type
Background: SARS-CoV2 virus is associated with 580,000 deaths and 32.5 million cases of COVID-19 infection in the United States. Data exist suggesting a correlation between blood type and disease acquisition and severity. No such data exist between blood type and disease response to convalescent pla...
Main Authors: | William R Hartman, Aaron S Hess, Joseph P Connor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Global Journal of Transfusion Medicine |
Subjects: | |
Online Access: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=1;spage=86;epage=88;aulast=Hartman |
Similar Items
-
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest
by: William R. Hartman, et al.
Published: (2020-10-01) -
Convalescent Plasma: An Old Trick for the Treatment of COVID-19
by: Reza Jafari, et al.
Published: (2020-07-01) -
The Convalescent Plasma Craze! Where Does India Stand?
by: Arcot J. Priyadarsini, et al.
Published: (2021-06-01) -
Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
by: Anna Moniuszko-Malinowska, et al.
Published: (2021-12-01) -
Rapid Clinical and Radiological Improvement in a Patient with Severe COVID-19 Infection Treated with Convalescent Plasma
by: Stephen Malnick, et al.
Published: (2021-05-01)